Sanitizer Demand Sparks Creativity: Compressed-Air Spray, ‘Shield’ Formula, Single-Use Convenience

COVID-19 drives hand sanitizer innovation as firms look to solve typical problems such as short microbe-kill treatment periods or risk of infection from sharing sanitizer bottles. Among launches, Breathe aerosol hand sanitizers use compressed air for faster application withouontact, while Disinfectant&Shield claims to kill germs for eight hours.

Hand sanitizer alcohol gel rub coronavirus virus protection on hands

Surging US demand for OTC hand sanitizers is spurring innovation in delivery and formulations that provide long-lasting microbe-kill capability, reduce the risk of person-to-person infection or offer easy-open, single-use convenience.

Products launched in response to the COVID-19 pandemic include Breathe continuous spray clean aerosol hand sanitizers that use compressed air...

More from Business

Private Label ‘Smart Imitation’ Of National Brands’ Packaging Not So Wise In US OTC Drug Sector

 

First Insight survey with 1,267 US consumers showed 44% are more likely to try a private label product “marketed as a dupe of a high-end product.” Providers of OTC drugs as well as other medical products in US would tread on thin regulatory ice with the practice.

Haleon Invests In State-Of-The-Art Oral Care R&D Facility In The UK

 
• By 

Haleon described the opening of a new oral care R&D facility in the UK as a “major investment reflecting our commitment to advancing science and innovation.”

Over The Counter: How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.

Lupin Goes For Growth With Indian Consumer Health Spin-Off

 
• By 

With annual sales approaching $20m, LupinLife Consumer Healthcare has ambitious growth plans for the Indian OTC market.

More from Health

Haleon Invests In State-Of-The-Art Oral Care R&D Facility In The UK

 
• By 

Haleon described the opening of a new oral care R&D facility in the UK as a “major investment reflecting our commitment to advancing science and innovation.”

Viatris Switches Innovative Dual Action Nasal Spray In The UK

 
• By 

Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.

Cloudy Tariff Conditions Expected To Linger In US

 

White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.